Related Experiment Video
Updated: Jun 25, 2026
07:57
Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
Lipid management in the geriatric patient
1Cardiovascular Institute, Mount Sinai Medical Center, One Gustave L. Levy Place, NY 10029, USA.
Endocrinology and Metabolism Clinics of North America
|February 17, 2009
Summary
Lipid therapy, including statins, offers significant cardiovascular event reduction in elderly patients, comparable to or exceeding benefits in younger individuals. Combination therapy may be needed for those not meeting cholesterol goals.
Area of Science:
- Cardiology
- Geriatrics
- Pharmacology
Background:
- Elderly individuals face elevated cardiovascular event risk.
- Lipid-lowering therapies are crucial for this demographic.
Purpose of the Study:
- To evaluate the efficacy and safety of lipid therapy in older adults.
- To compare statin benefits in geriatric versus younger populations.
Main Methods:
- Review of primary and secondary prevention trials involving lipid-lowering agents.
- Analysis of combination therapy strategies for cholesterol management.
Main Results:
- Statin therapy demonstrates equivalent or superior cardiovascular event reduction in geriatric patients.
- Combination therapy is beneficial for patients with suboptimal cholesterol levels or dyslipidemia.
Conclusions:
- Lipid therapy, particularly statins, is highly effective in reducing cardiovascular events in the elderly.
- Careful management of polypharmacy and drug interactions is essential to mitigate side effects of high-dose statin therapy.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...